Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | Southern Health and Social Care Trust |
| Main Category: | Goods |
| Procurement Method: | Direct award |
| Method Rationale: | As per Section 41 of the PA2023, a direct award is made in line with Schedule 5 of the PA2023 paragraph 5 "due to the supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required," This product is the only commercially available from one supplier and no competition or alternative exists for this product. |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 3 September 2025 |
All 3 notices for this procurement, oldest first.
Revcovi
Revcovi
Revcovi
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £3,996,000 |
| Award status: | Pending |
Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.
Published contracts in the last 12 months
32
total contracts
£8.1m
total value
£8,099,773
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Application Deadline: | — |
| Contract Start Date: | — |
| Contract End Date: | — |
| Contract Duration: | NaN years |
| Procurement ID (OCID): | ocds-h6vhtk-0592c8 |
| Notice Reference: | 053381-2025 |